Potassium Ion

Potassium Ion

SCHEMBL3272040

O=P([O-])(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F.[K+]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.33
PGK1 P00558 1/20 0.30
PGK2 P07205 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15136602 0.93 KDM4E (0.30) PGK1PGK2
SCHEMBL15136323 0.93 PGK1 (0.30) PGK1PGK2
Lithium Ion SCHEMBL4017890 0.93 PGK1 (0.30) PGK1PGK2
SCHEMBL12469732 0.93 PGK1 (0.30) PGK1PGK2
SCHEMBL16346604 0.93 PGK1 (0.30) PGK1PGK2
Silver SCHEMBL18668196 0.93 PGK1 (0.30) PGK1PGK2
Tetramethylammonium Ion SCHEMBL12469916 0.85
Potassium Ion SCHEMBL6053259 0.80 SLC34A1 (0.33) SLC34A1PGK1PGK2
Potassium Ion SCHEMBL6053281 0.79 CA1 (0.31)
Tetrylammonium SCHEMBL3271235 0.77 TSHR (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541488-B2 Process for the preparation of mono- and bis(fluoroalkyl)phosphoranes and the corresponding acids and phosphates MERCK PATENT GMBH (DE) 2009-06-02 US claimed
US-8846922-B2 Functionalized fluoroalkyl fluorophosphate salts MERCK PATENT GMBH (DE) 2014-09-30 US disclosed
US-20130197228-A1 FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-01 US disclosed
EP-1495035-B1 METHOD FOR THE PRODUCTION OF BIS(PERFLUOROALKYL)PHOSPHINIC ACIDS AND THE SALTS THEREOF MERCK PATENT GMBH (DE) 2010-06-30 EP disclosed
US-7541488-B2 Process for the preparation of mono- and bis(fluoroalkyl)phosphoranes and the corresponding acids and phosphates MERCK PATENT GMBH (DE) 2009-06-02 US disclosed
EP-1685143-B1 METHOD FOR THE PRODUCTION OF MONO(FLUOROALKYL)PHOSPHORANES, BIS(FLUOROALKYL)PHOSPHORANES, AND THE CORRESPONDING ACIDS AND PHOSPHATES MERCK PATENT GMBH (DE) 2007-11-28 EP disclosed
US-20070088176-A1 Process for the preparation of mono-and bis(fluoroalkyl)phosphoranes and the corresponding acids and phosphates MERECK PATENT GMBH (DE) 2007-04-19 US disclosed
US-7202379-B2 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof MERCK PATENT GMBH (DE) 2007-04-10 US disclosed
US-7145004-B2 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates MERCK PATENT GESELLSCHAFT (DE) 2006-12-05 US disclosed
EP-1685143-A1 METHOD FOR THE PRODUCTION OF MONO(FLUOROALKYL)PHOSPHORANES, BIS(FLUOROALKYL)PHOSPHORANES, AND THE CORRESPONDING ACIDS AND PHOSPHATES Merck Patent GmbH (DE) 2006-08-02 EP disclosed
US-20050256334-A1 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof MERCK PATENT GMBH (DE) 2005-11-17 US disclosed
US-20050222411-A1 Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates MERCK PATENT GMBH (DE) 2005-10-06 US disclosed
WO-2005049628-A1 METHOD FOR THE PRODUCTION OF MONO(FLUOROALKYL)PHOSPHORANES, BIS(FLUOROALKYL)PHOSPHORANES, AND THE CORRESPONDING ACIDS AND PHOSPHATES MERCK PATENT GMBH (DE) 2005-06-02 WO disclosed
EP-1495036-A1 METHOD FOR THE PRODUCTION OF MONOHYDRO-PERFLUOROALKANES, BIS(PERFLUOROALKYL)PHOSPHINATES, AND PERFLUOROALKYLPHOSPHONATES MERCK PATENT GmbH (DE) 2005-01-12 EP disclosed
EP-1495035-A1 METHOD FOR THE PRODUCTION OF BIS(PERFLUOROALKYL)PHOSPHINIC ACIDS AND THE SALTS THEREOF MERCK PATENT GmbH (DE) 2005-01-12 EP disclosed
WO-2003087111-A1 METHOD FOR THE PRODUCTION OF MONOHYDRO-PERFLUOROALKANES, BIS(PERFLUOROALKYL)PHOSPHINATES, AND PERFLUOROALKYLPHOSPHONATES MERCK PATENT GMBH (DE) 2003-10-23 WO disclosed
WO-2003087110-A1 METHOD FOR THE PRODUCTION OF BIS(PERFLUOROALKYL)PHOSPHINIC ACIDS AND THE SALTS THEREOF MERCK PATENT GMBH (DE) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088176-A1 Process for the preparation of mono-and bis(fluoroalkyl)phosphoranes and the corresponding acids and phosphates PPIP5K2, PHOSPHO1, PFKFB1 SLC34A1 231/4885PGK1 171/4885PGK2 271/4885
US-20130197228-A1 FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS INPPL1, INPP5D, PLCB3 SLC34A1 94/4885PGK1 3367/4885PGK2 3076/4885
US-20050222411-A1 Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates PFAS, PFKFB2, PHOSPHO1 SLC34A1 601/4885PGK1 670/4885PGK2 664/4885
US-20050256334-A1 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof PFAS, PFKFB1, PFKFB4 SLC34A1 367/4885PGK1 419/4885PGK2 534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.